Julie Cooke Net Worth & Insider Trades

Julie Cooke - Chief Human Resources Officer, Neurocrine Biosciences Inc

As of November 10, 2022

What is Julie Cooke's Net Worth?

The current estimated net worth of Neurocrine Biosciences Inc's Chief Human Resources Officer, Julie Cooke, is estimated to be about $4.03M . Julie Cooke owns about 15,102 units of Neurocrine Biosciences Inc common stock. In the last 3 years at Neurocrine Biosciences Inc, Julie Cooke has sold an estimated value of $3.57M worth.

What is Julie Cooke's Past Insider Trading?

Julie Cooke's largest purchase order was 8,408 units , worth over $681.47K on November 4, 2022. Julie Cooke's largest sale order was 8,408 units , worth over $1.05M on November 4, 2022. In total, Julie Cooke has made about 15 transactions over 3 years of their time at Neurocrine Biosciences Inc. Julie Cooke usually trades in February, with the busiest year in 2022 and 2020. The most recent transaction was a sale order of 5,592 units , worth over $698.95K on November 10, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Julie Cooke's' Mailing Address?

  • Mailing address is C/o Neurocrine Biosciences, Inc. 12780 el Camino Real San Diego CA 92130 CA

Neurocrine Biosciences Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Compensation
Total
Kevin C. Gorman, Ph.D. 2018 $675,000 $425,250 $4,486,852 $2,998,832 $47,045 $8,632,979
Kevin C. Gorman, Ph.D. 2019 $725,000 $667,000 $6,000,525 $2,000,071 $58,230 $9,450,826
Kevin C. Gorman, Ph.D. 2020 $775,000 $542,500 $7,124,633 $5,375,188 $63,311 $13,880,632
Matthew C. Abernethy 2018 $420,000 $199,500 - $1,996,506 $69,741 $2,685,747
Matthew C. Abernethy 2019 $495,600 $284,970 $3,750,345 $1,250,035 $42,170 $5,823,120
Matthew C. Abernethy 2020 $545,200 $190,820 $2,999,869 $2,500,266 $45,021 $6,281,176
Eric Benevich 2018 $432,600 $205,485 $1,496,335 $1,499,417 $38,768 $3,672,605
Eric Benevich 2019 $467,200 $280,320 $3,750,345 $1,250,035 $45,547 $5,793,447
Eric Benevich 2020 $499,900 $199,960 $2,999,869 $3,000,257 $48,974 $6,748,960
Kyle W. Gano, Ph.D. 2018 $403,100 $191,473 $1,309,024 $2,656,575 $8,069 $4,568,241
Kyle W. Gano, Ph.D. 2019 $443,400 $266,040 $3,000,285 $1,000,076 $16,171 $4,725,972
Kyle W. Gano, Ph.D. 2020 $487,700 $207,273 $3,749,799 $2,750,210 $16,751 $7,211,733
Eiry W. Roberts, M.D. 2018 $490,700 $220,800 $2,863,700 $4,053,869 $671,554 $8,300,623
Eiry W. Roberts, M.D. 2019 $538,200 $309,465 $3,000,285 $1,000,076 $51,889 $4,899,915
Eiry W. Roberts, M.D. 2020 $575,900 $215,963 $2,624,855 $2,375,242 $56,073 $5,848,033
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm

What are Neurocrine Biosciences Inc's Past Insider Trades?

Neurocrine Biosciences Inc's most recent insider trade came on January 10, 2023 by Eric Benevich who sold 400 units worth $50K . In the last 20 years, insiders at Neurocrine Biosciences Inc have sold an estimated value of $379.31M and bought an estimated value of $67.75M worth of shares. Insider trading is most common in May, with the busiest year in 2017. The most active traders at the company are Dimitri Grigoriadis, Chief Research Officer,  Gary Lyons, Director,  and Haig Bozigian, Chief Development Officer .

NEUROCRINE BIOSCIENCES INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1